Palmitoylethanolamide (PEA) reduces sensitivity to pain in the central and peripheral nervous systems and increases pain modulation, says a recent study from Austrian researchers.
Palmitoylethanolamide (PEA) is a safer and more pervasive therapeutic alternative to cannabidiol, say the authors of the Gencor Pacific-commissioned review, ‘Palmitoylethanolamide: A Potential Alternative to Cannabidiol.’
A wrinkled type of ‘super pea,’ containing higher levels of gut-friendly ‘resistant starch,’ may prove beneficial to those at risk of type 2 diabetes, due to its ability to control blood sugar levels, a study thinks.
A Palmitoylethanolamide (PEA) supplement matches the efficacy of ibuprofen for reducing pain severity and duration of headaches creating an exciting opportunity within the eSports category, says Gencor.
